急性失代偿期肝硬化诊治及其预后的研究进展  

Advances in the diagnosis,treatment,and prognosis of acute decompensatory cirrhosis

作　　者：许晓梅 秦波[1] Xu Xiaomei;Qin Bo(Department of Infectious Diseases,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)

机构地区：[1]重庆医科大学附属第一医院感染科,重庆400016

出　　处：《中华肝脏病杂志》2023年第7期756-759,共4页Chinese Journal of Hepatology

基　　金：重庆市2020年科卫联合医学科研项目(2020MSXM026);四川省预防医学会医院感染与控制相关课题项目(SCGK202115)。

摘　　要：急性失代偿期肝硬化(ADC)是失代偿期肝硬化患者常见的入院、再入院及死亡原因,给患者及其家庭和社会造成了沉重的负担。现从ADC概念的演变、发病机制、治疗、转归及预后模型等方面对ADC的研究进展进行综述,为ADC的防治提供新思路。Acute decompensatory cirrhosis is a common cause of hospital admission,readmission,and death,causing a heavy burden on patients,their families,and society.This article reviews the research advancement from the perspectives of concept evolution,pathogenesis,treatment,outcome,and prognosis models,providing new ideas for preventing and treating acute decompensatory cirrhosis.

关 键 词：失代偿性肝硬化 急性 发病机制 治疗转归 预后 

分 类 号：R575.2[医药卫生—消化系统]